Alexion Pharmaceuticals, Inc. (ALXN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN)

ALXN 182.50

0.0%

Jul 28 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (761)	3/26/2007 9:26:17 PM
From: Robohogs	Read Replies (2) of 824

2 thoughts - First, the cap on many medical plans is $1-2 MM USD (mine is 2) - that drug if needed would kill overall healthcare plan benefit. Use it and nothing else covered. How can they possibly think they are doing the right thing? Second, what do insurance companies do if the co-pay is not really met (i.e., refunded by the drug seller)? Seems this could be problematic as it could lead to price set at any level with no effective co-pay. I am assuming once drug company gets involved, insurance is no longer good and drug company gets ZERO revenue. Anyone know? Jon

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next